About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials | 16,773 Studies Recruiting

Clinical TrialsBreast Cancer

Breast Cancer Clinical Trials

Browse 16,773 clinical trials for breast cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7321-7340 of 16,773 trials

CompletedLapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.This study will examine safety and efficacy of Lapatinib in combination with a standard neoadjuvant chemotherapy including 5FU, Epirubicin, Cyclophosphamide and Paclitaxel.NCT00524303·Fountain Valley, California and 22 others RecruitingBergonie Institute Breast Cancer DatabaseA database of breast cancer patients was established at Institute Bergonié since the 90s , to assess patients' survival, assess practice, search for prognostic factors.NCT02893761·Bordeaux CompletedAmifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003269·La Jolla, California

Related Searches

breast carcinomatrials

Data from ClinicalTrials.govTerms

TerminatedPembrolizumab + Paclitaxel in HR+/HER2- Non-luminal (by PAM50) Advanced Breast Cancer After CDK4/6 Inhibitor ProgressionThis is an open-label, single arm, multicenter phase II study evaluating treatment with pembrolizumab in combination with paclitaxel in patients with locally advanced or…NCT04251169·L'Hospitalet de Llobregat, Barcelona and 6 others

RecruitingTai Chi for Reducing Aromatase Inhibitor-Induced ArthralgiaThe objective of the pilot RCT is to evaluate the feasibility and acceptability of a Tai Chi intervention "TaiChi4Joint" vs. an HE AC group for relieving AIIA in women with…NCT07737951·Philadelphia, Pennsylvania

CompletedCoated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer SurgeryThis is a 90-day study to evaluate cosmetic outcome and Surgical Site Infection in approximately 100 patients from 6 centers in China undergoing scheduled modified radical…NCT00768222·Beijing and 5 others

Active not recruitingSystem-integrated Point-of-Care Ultrasound in Breast Cancer ScreeningTo assess the feasibility, safety, and clinical performance of community-based breast cancer screening incorporating clinical breast exam and short-termed trained examiners…NCT07462351·Arba Minch, Gamo Zone

CompletedTelenursing and Breast Cancer: The Turkish CaseThis study aims to determine the effectiveness of telenursing services on chemotherapy symptoms and comfort levels in patients with breast cancer in Turkey.NCT04480229

TerminatedChemotherapy Monitoring by ctDNA in HER2- Metastatic Breast CancerThis is a one-arm, single site, open-label phase II study.NCT04720729·Paris

CompletedPrevention of Cardiac Dysfunction During Breast Cancer TherapyBreast cancer is the most common cancer among women.NCT03760588·Lørenskog and 3 others

TerminatedEPR Tumor Oximetry With CE India InkIt has been well established that malignant tumors tend to have low levels of oxygen and that tumors with very low levels of oxygen are more resistant to radiotherapy and other…NCT03321903·Lebanon, New Hampshire

Not yet recruitingReduction of Neoadjuvant Treatment in Early Triple-Negative Breast CancerThis multicenter phase II study evaluates a de-escalation strategy of neoadjuvant chemo-immunotherapy in patients with stage II early triple-negative breast cancer and…NCT07857486

CompletedDocetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00079170·Bethesda, Maryland

TerminatedPilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast CancerThis is a pilot "window of opportunity" clinical study in patients with operable breast cancer investigating use of reparixin as single agent in the time period between clinical…NCT01861054·Indianapolis, Indiana and 8 others

RecruitingEvaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological CancerThis is a multicenter randomized trial in breast cancer patients reporting cancer-related fatigue to evaluate the efficacy and safety of Qiseng® based on extract of American…NCT05241405·Amiens and 9 others

CompletedEpothilone B in Treating Patients With CNS Metastases From Breast CancerRATIONALE: Drugs used in chemotherapy, such as epothilone B, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00450866·Boston, Massachusetts and 4 others

RecruitingStudy of AVZO-021 in Patients With Advanced Solid TumorsThis study, the first clinical trial of AVZO-021, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and anti-tumor effects of…NCT05867251·New Haven, Connecticut and 12 others

UnknownTargeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast CancerTo explore the genetic background of patients with HER2 positive breast cancer that benefit from trastuzumab combined with neoadjuvant chemotherapy, identify clinically actionable…NCT03728829·Shijiazhuang, Hebei

RecruitingA Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.A phase 1, multicenter, open label, non-randomized dose escalation and dose expansion study to examine the maximum tolerated dose, (MTD), minimum effective dose (MED) and/or…NCT06022029·Los Angeles, California and 15 others

TerminatedSuberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast CancerThis phase II trial is studying how well suberoylanilide hydroxamic acid works in treating patients with progressive stage IV breast cancer.NCT00132002·Duarte, California

PreviousPage 367 of 839Next